Publication | Open Access
Camrelizumab in combination with apatinib in second-line or above therapy for advanced primary liver cancer: cohort A report in a multicenter phase Ib/II trial
69
Citations
18
References
2021
Year
NCT03092895.
| Year | Citations | |
|---|---|---|
Page 1
Page 1